The IDIBAPS research group Systemic vasculitis, led by Maria C. Cid, has published a new study in the journal Annals of the Rheumatic Diseases that explores the mechanisms of action of the drug Tocili...
Read moreHan demostrado que el mal control glucémico durante la progresión de la diabetes mellitus tipo 2 (DM2) conlleva un mayor riesgo de desarrollar enfermedades cardiovasculares.
Read moreThe PREFER trial has been recognised as innovative for using oral iron molecules and targeting a particularly vulnerable population: large people with advanced heart disease, usually excluded from oth...
Read moreLa investigación analiza la evolución de biomarcadores clave y parámetros de imagen cardíacos durante el tratamiento con sacubitrilo-valsartán, con el objetivo de mejorar el seguimiento clínico ...
Read moreThe Aortyx team is developing a minimally invasive solution for aortic dissection, essentially a tear in the aortic wall. To this end, they have created a steerable catheter that is inserted through t...
Read moreIt has been designed a strategy to inhibit the expression of PCSK9, a protein that plays a decisive role in modulating plasma levels of low-density lipoprotein cholesterol (LDL-C). The new method, bas...
Read moreEl análisis reveló diferencias significativas en el perfil cardiometabólico entre las poblaciones de estudio, lo que subraya la importancia de utilizar valores de referencia adaptados a cada contex...
Read moreUn estudio muestra el impacto cardiovascular del síndrome metabólico inducido mediante una dieta abundante en grasas y azúcares. La investigación, cuyos resultados se han publicado recientemente e...
Read moreFollowing a Mediterranean diet is associated with a lower likelihood of starting the three main types of psychiatric medication - antidepressants, anxiolytics, and antipsychotics - as well as a lower ...
Read moreAortyx, the medical device company backed by IQS-URL, has raised 13.8 million euros in Series A funding to advance its bioabsorbable aortic patch to the first clinical trials in patients within two ye...
Read moreThe new study, conducted in animal models, describes a repressor factor that blocks brown fat activity: the ACBP protein. Under normal conditions, this protein would regulate when brown fat activity i...
Read moreResearchers from Hospital Clínic Barcelona and IDIBAPS have participated in the development of the first European clinical guidelines dedicated exclusively to the management of transjugular intrahepa...
Read more